Damien Sene

Overview

Best Publications

• Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

  David Saadoun;Michelle Rosenzwajg;Florence Joly;Adrien Six

  868
  Citations

• Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

  Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  592
  Citations

• Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia.

  David Saadoun;Mathieu Resche Rigon;Damien Sene;Benjamin Terrier

  333
  Citations

• PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.

  Asma Beldi-Ferchiou;Marion Lambert;Marion Lambert;Stéphanie Dogniaux;Frédéric Vély

  319
  Citations

• Expansion of Autoreactive Unresponsive CD21−/low B Cells in Sjögren's Syndrome–Associated Lymphoproliferation

  D Saadoun;B Terrier;J Bannock;T Vazquez

  268
  Citations

• The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

  Unknown

  263
  Citations

• Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

  Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  262
  Citations

• Antiphospholipid antibodies, antiphospholipid syndrome and infections.

  Damien Sène;Jean-Charles Piette;Patrice Cacoub

  250
  Citations

• Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

  Alexis Mathian;Matthieu Mahevas;Julien Rohmer;Mathilde Roumier

  242
  Citations

• PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

  Patrice Cacoub;David Saadoun;Nicolas Limal;Damien Sene

  236
  Citations

• Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

  H Vallet;S Riviere;A Sanna;A Deroux

  229
  Citations

• Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

  Pilar Brito-Zerón;Pilar Brito-Zerón;Nihan Acar-Denizli;Margit Zeher;Astrid Rasmussen

  223
  Citations

• Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.

  Jacques-Eric Gottenberg;Raphaèle Seror;Corinne Miceli-Richard;Joelle Benessiano

  221
  Citations

• Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

  Patrice Cacoub;Aurélien Delluc;David Saadoun;Dan Avi Landau

  215
  Citations

• Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients

  David Lebeaux;Camille Francès;Stéphane Barete;Bertrand Wechsler

  198
  Citations

• Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.

  Benjamin Terrier;Ivan Bièche;Thierry Maisonobe;Ingrid Laurendeau

  183
  Citations

• Lupus enteritis: from clinical findings to therapeutic management.

  Peter Janssens;Laurent Arnaud;Laurent Arnaud;Lionel Galicier;Alexis Mathian

  178
  Citations

• Rituximab may form a complex with iGmκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus–induced vasculitis

  Damien Sène;Pascale Ghillani-Dalbin;Zahir Amoura;Lucile Musset

  176
  Citations

• Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

  Hélène Vallet;Pascal Seve;Lucie Biard;Jean Baptiste Fraison

  175
  Citations

• Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis

  D Saadoun;M Resche-Rigon;D Sene;L Perard

  168
  Citations

• Causes and Predictive Factors of Mortality in a Cohort of Patients with Hepatitis C Virus-related Cryoglobulinemic Vasculitis Treated with Antiviral Therapy

  Dan-Avi Landau;Samy Scerra;Damien Sene;Mathieu Resche-Rigon

  72
  Citations